Evaluation of the surface adhesion molecules identified a markedly altered expression pattern of the integrin, CD49d, and the tetraspanin, CD82, in the index case when compared to similar low-risk CLL cases. The gene discussed is CD82; the disease is B-cell chronic lymphocytic leukemia.